Therapeutic Targeting of MZF1‐AS1 /PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression

Advanced Science - Germany
doi 10.1002/advs.201900581
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Long Noncoding RNA RHPN1-AS1 Promotes Colorectal Cancer Progression via Targeting miR-7-5p/OGT Axis

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Targeting the Metabolic Axis ACSL/SCD in Colorectal Cancer Progression by Therapeutic miRNAs: miR−19b−1 Role

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2017English

Long Noncoding RNA NNT-AS1 Promotes Hepatocellular Carcinoma Progression and Metastasis Through miR-363/CDK6 Axis

Oncotarget
Oncology
2017English

Long Noncoding RNA DLX6-AS1 Promotes Renal Cell Carcinoma Progression via miR-26a/PTEN Axis

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2017English

The Proline Regulatory Axis and Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System

Anticancer Research
MedicineCancer ResearchOncology
2017English

OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy